The UW–Madison School of Pharmacy’s PearlRx — the nation’s largest research network of its kind — connects pharmacists and researchers to improve Wisconsin practice.
Research
From Lab to Clinic: A Mission Against Epilepsy
Professor Barry Gidal, a nationally recognized leader in epilepsy research, is driving progress in treatment and patient advocacy.
Unlocking Cocaine’s Grip on the Brain
Professor Lingjun Li and lab members reveal the crucial role of neuropeptides in cocaine addiction, paving the way for novel therapies.
New NIH Grant to Fight Triple-Negative Breast Cancer
With support from the NIH, Assistant Professor Quanyin Hu uses a two-step system to attack triple-negative breast cancer.
New Grant Fuels Pediatric Brain Cancer Treatments
With V Foundation funding, Assistant Professor Quanyin Hu aims to improve a cancer-killing hydrogel to improve outcomes for pediatric GBM patients.
UW Researchers Find Links Between Microbial Bile Acids and the Risk of Colon Cancer
UW researchers find previously unknown links between microbial bile acids and the risk of colon cancer.
Platelets as Protein Degraders
A cutting-edge platform developed by Assistant Professor Quanyin Hu uses protein-degrading platelets to suppress tumor regrowth and bolster immune response after surgery.
Addressing a Silent Threat to Seniors
Groundbreaking research from School of Pharmacy faculty reveals alarming misuse of OTC medications by older adults and offers a simple solution.
Three Research Forward Awards Fuel Faculty Innovation
Professors Timothy Bugni, Lingjun Li, and Weiping Tang have received UW–Madison grants to advance their innovative multidisciplinary research.
Tagged for Destruction
Professor Weiping Tang creates a new type of molecule to tag proteins on the surface of cancer cells for degradation.